A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout | MicrobiomeTrials
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2024-03-18Est. Completion: 2025-07-30
Enrollment target: 306 participants
Locations
The University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States
Orthopedic Physicians Alaska - Rheumatology and Infusion, Anchorage, Alaska, United States
Arizona Arthritis and Rheumatology Associates - Chandler, Chandler, Arizona, United States
Arizona Arthritis and Rheumatology Rese, Flagstaff, Arizona, United States
Arizona Arthritis & Rheumatology Research, PLLC, Gilbert, Arizona, United States
Arizona Arthritis & Rheumatology Research, PLLC, Mesa, Arizona, United States
Arizona Arthritis and Rheumatology Research, PLLC, Mesa, Arizona, United States
Arizona Arthritis and Rheumatology Research, PLLC, Phoenix, Arizona, United States
Arizona Arthritis and Rheumatology Research, Phoenix, Arizona, United States
Arizona Arthritis & Rheumatology Research, PLLC, Sun City, Arizona, United States
Arizona Arthritis and Rheumatology, Tucson, Arizona, United States
Covina Arthritis Clinic, Covina, California, United States
Medvin Clinical Research- Riverside, Hemet, California, United States
Velocity Clinical Research - Boise - ERN - PPDS, North Hollywood, California, United States
Other microbiome trials you might be interested in